APA

Golan T., Grenader T., Ohana P., Amitay Y., Shmeeda H., La-Beck N. M., Tahover E., Berger R. & Gabizon A. A. (20160713). Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. : Cancer medicine.

Chicago

Golan Talia, Grenader Tal, Ohana Patricia, Amitay Yasmine, Shmeeda Hilary, La-Beck Ninh M, Tahover Esther, Berger Raanan and Gabizon Alberto A. 20160713. Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. : Cancer medicine.

Harvard

Golan T., Grenader T., Ohana P., Amitay Y., Shmeeda H., La-Beck N. M., Tahover E., Berger R. and Gabizon A. A. (20160713). Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. : Cancer medicine.

MLA

Golan Talia, Grenader Tal, Ohana Patricia, Amitay Yasmine, Shmeeda Hilary, La-Beck Ninh M, Tahover Esther, Berger Raanan and Gabizon Alberto A. Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. : Cancer medicine. 20160713.